Triage of Patients With Moderate to Severe Heart Failure

被引:43
作者
Thorvaldsen, Tonje [1 ,2 ]
Benson, Lina [3 ]
Stahlberg, Marcus [1 ,2 ]
Dahlstrom, Ulf [4 ,5 ]
Edner, Magnus [1 ]
Lund, Lars H. [1 ,2 ]
机构
[1] Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Sci & Educ, S-17176 Stockholm, Sweden
[4] Linkoping Univ, Fac Hlth Sci, Div Cardiovasc Med, Dept Med & Hlth Sci, Linkoping, Sweden
[5] Cty Council Ostergotland, Dept Cardiol UHL, Linkoping, Sweden
关键词
heart failure; heart transplantation; left ventricular assist device; palliative care; referral; VENTRICULAR-ASSIST-DEVICES; TRANSPLANTATION CANDIDATES; INTERNATIONAL SOCIETY; SURVIVAL; CARE; MODEL; ASSOCIATION; MORTALITY; SELECTION; STANDARD;
D O I
10.1016/j.jacc.2013.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to evaluate simple criteria for referral of patients from the general practitioner to a heart failure (HF) center. Background In advanced HF, the criteria for heart transplantation, left ventricular assist device, and palliative care are well known among HF specialists, but criteria for referral to an advanced HF center have not been developed for generalists. Methods We assessed observed and expected all-cause mortality in 10,062 patients with New York Heart Association (NYHA) functional class III to IV HF and ejection fraction < 40% registered in the Swedish Heart Failure Registry between 2000 and 2013. Next, 5 pre-specified universally available risk factors were assessed as potential triggers for referral, using multivariable Cox regression: systolic blood pressure <= 90 mm Hg; creatinine >= 160 mmol/l; hemoglobin <= 120 g/l; no renin-angiotensin system antagonist; and no beta-blocker. Results In NYHA functional class III to IV and age groups <= 65 years, 66 to 80 years, and > 80 years, there were 2,247, 4,632, and 3,183 patients, with 1-year observed versus expected survivals of 90% versus 99%, 79% versus 97%, and 61% versus 89%, respectively. In the age <= 80 years group, the presence of 1, 2, or 3 to 5 of these risk factors conferred an independent hazard ratio for all-cause mortality of 1.40, 2.30, and 4.07, and a 1-year survival of 79%, 60%, and 39%, respectively (p < 0.001). Conclusions In patients <= 80 years of age with NYHA functional class III to IV HF and ejection fraction < 40%, mortality is predominantly related to HF or its comorbidities. Potential heart transplantation/left ventricular assist device candidacy is suggested by >= 1 risk factor and potential palliative care by multiple universally available risk factors. These patients may benefit from referral to an advanced HF center. (C) (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:661 / 671
页数:11
相关论文
共 29 条
[1]   Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure [J].
Eklind-Cervenka, Maria ;
Benson, Lina ;
Dahlstrom, Ulf ;
Edner, Magnus ;
Rosenqvist, Marten ;
Lund, Lars H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (02) :175-182
[2]   Adherence to heart failure quality-of-care indicators in US hospitals - Analysis of the ADHERE Registry [J].
Fonarow, GC ;
Yancy, CW ;
Heywood, JT .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (13) :1469-1477
[3]   Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis [J].
Fonarow, GC ;
Adams, KF ;
Abraham, WT ;
Yancy, CW ;
Boscardin, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :572-580
[4]   Selecting patients for heart transplantation: Comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM) [J].
Goda, Ayumi ;
Williams, Paula ;
Mancini, Donna ;
Lund, Lars H. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (11) :1236-1243
[5]   A time to be born and a time to die [J].
Goldberg, Lee R. ;
Jessup, Mariell .
CIRCULATION, 2007, 116 (04) :360-362
[6]   CANCER SURVIVAL CORRECTED FOR HETEROGENEITY IN PATIENT WITHDRAWAL [J].
HAKULINEN, T .
BIOMETRICS, 1982, 38 (04) :933-942
[7]   Physician attitudes toward end-stage heart failure: A national survey [J].
Hauptman, Paul J. ;
Swindle, Jason ;
Hussain, Zainal ;
Biener, Lois ;
Burroughs, Thomas E. .
AMERICAN JOURNAL OF MEDICINE, 2008, 121 (02) :127-135
[8]   Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients [J].
Kirklin, James K. ;
Naftel, David C. ;
Kormos, Robert L. ;
Stevenson, Lynne W. ;
Pagani, Francis D. ;
Miller, Marissa A. ;
Baldwin, J. Timothy ;
Young, James B. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (02) :141-156
[9]   Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? [J].
Kirklin, James K. ;
Naftel, David C. ;
Pagani, Francis D. ;
Kormos, Robert L. ;
Stevenson, Lynne ;
Miller, Marissa ;
Young, James B. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03) :584-603
[10]   The Seattle heart failure model - Prediction of survival in heart failure [J].
Levy, WC ;
Mozaffarian, D ;
Linker, DT ;
Sutradhar, SC ;
Anker, SD ;
Cropp, AB ;
Anand, I ;
Maggioni, A ;
Burton, P ;
Sullivan, MD ;
Pitt, B ;
Poole-Wilson, PA ;
Mann, DL ;
Packer, M .
CIRCULATION, 2006, 113 (11) :1424-1433